Jen L, PhD
banner
drjkyl.bsky.social
Jen L, PhD
@drjkyl.bsky.social
Executive Editor/Team Lead Open Access Science & Medicine Journals Sage Publishing
Opinions = mine

http://linkedin.com/in/jlovick-editor

#oncology #cancerresearch #medicine #biology #cardiology #neurology #microbiology #publichealth #healthcare
Pinned
Introduction - PhD working in academic publishing, lead a team of amazing Managing Editors that support @sagepub.com @journals.sagepub.com 's Open Access Biomedical Journals. I'll be sharing recent articles from our journals that I find interesting. Happy to connect with researchers! 📖🔬🧪💊⚕️
Reposted by Jen L, PhD
New Case Report online!
Spinocerebellar ataxia type 3 (SCA3) masquerading as atypical parkinsonism?
🔎The findings underscore the importance of genetic testing in atypical parkinsonism and the need for personalized deep-brain stimulation strategies in SCA3.
journals.sagepub.com/doi/full/10....
February 6, 2026 at 1:38 PM
Reposted by Jen L, PhD
Early NSCLC is entering a new era. Broad NGS profiling now identifies actionable mutations that guide adjuvant EGFR/ALK‑targeted therapy, influence immunotherapy decisions, and support ctDNA‑based MRD monitoring.
🔗 buff.ly/FKnT16B
#NSCLC #LungCancer #NGS #ctDNA #MRD #PrecisionOncology
February 7, 2026 at 8:15 AM
Reposted by Jen L, PhD
Review on pregnancy & breast cancer in young women: PrBC vs PPBC distinctions, chemo during pregnancy (incl. taxanes after 1st trimester), POSITIVE trial on ET interruption, and fertility preservation gaps for targeted agents.
🔗 buff.ly/ZDZelh2
#BreastCancer #YWBC
February 7, 2026 at 6:03 PM
Reposted by Jen L, PhD
Top Read Papers on Natural Product Communications - February 2026

💡2. Therapeutic Value of Plant Saponins, Challenges and Opportunities: A Review

journals.sagepub.com/doi/10.1177/...
February 9, 2026 at 9:26 AM
Reposted by Jen L, PhD
New research online!
What is the real-world effectiveness and tolerability of #lasmiditan in the acute treatment of #migraine?

journals.sagepub.com/doi/full/10....
February 9, 2026 at 3:01 PM
Reposted by Jen L, PhD
A new review examines how gut microbiota influence response and toxicity to neoadjuvant chemoradiotherapy in LARC. Beneficial species (e.g., Akkermansia, Alistipes) may enhance treatment effect, while pathogens like F. nucleatum may drive resistance.
🔗 buff.ly/PefDIka
February 10, 2026 at 8:15 AM
Reposted by Jen L, PhD
Is intravenous immunoglobulin (IVIG) therapy effective in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) patients with #diabetes mellitus?

Check out this new prospective study by Samir Macwan and colleagues to find out more:
journals.sagepub.com/doi/full/10....
February 10, 2026 at 11:12 AM
Prognostic value of ctDNA-derived maximum somatic allele frequency in patients with metastatic gastric cancer
@tamedoncol.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#biomarker #cancerresearch #prognosis #oncology #openaccess
February 9, 2026 at 10:00 PM
Transfusion-induced hemolysis in warm autoimmune hemolytic anemia with autoantibodies that have anti-e specificity: a case report and systematic review of the literature

Therapeutic Advances in Hematology
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#medicine #treatment #openaccess
February 9, 2026 at 9:58 PM
Applicability of colon capsule endoscopy in FIT-positive individuals unable or unwilling to undergo colonoscopy within a colorectal cancer screening programme

Therapeutic Advances in Gastrointestinal Endoscopy
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#oncology #openaccess
February 9, 2026 at 9:56 PM
Tenapanor is associated with earlier and sustained symptom relief in IBS-C: a post hoc analysis
@tagastroenterol.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#gastroenterology #abdominal #IBS #medicine #openaccess
February 9, 2026 at 9:53 PM
Clinical outcomes of treatments for patients with refractory metastatic colorectal cancer: a systematic literature review and network meta-analysis
@tamedoncol.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#cancertreatment #combinationtherapy #oncology #openaccess
February 9, 2026 at 9:51 PM
Integration of pre‑existing cardiovascular comorbidity into CDK4/6 inhibitor selection for breast cancer

Therapeutic Advances in Drug Safety
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#womenshealth #cardiotoxicity #oncology #cancertreatment #openaccess
February 9, 2026 at 9:48 PM
From Simple Scores to Intelligent Systems: Encouraging the Development, Validation and Adoption of Robust Prognostic Tools in Small Cell Lung Cancer
@tcrtcancer.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#SCLC #biomarker #deeplearning #oncology #cancer #openaccess
February 6, 2026 at 11:22 PM
Ga-68-Edotreotide PET/CT SSTR Total Tumor Volume as a Predictor of Outcome in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors
@cancer-control.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#NETs #medicalimaging #cancertreatment #oncology #openaccess
February 6, 2026 at 11:19 PM
A preliminary preclinical assessment of macromolecular crowding in tissue engineering

Science Progress
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#celltransplantation #stromalcells #bioengineering #medicine #openaccess
February 6, 2026 at 11:16 PM
Efgartigimod as a treatment for people with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): a plain language summary of publication of the ADHERE trial
@taneuroldisord.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#qualityoflife #PLSP #clinicaltrial
February 6, 2026 at 11:13 PM
Skin cancer awareness and sun protection advice for outdoor workers in Australia: Review of communication channels to optimise reach and relevance

Digital Health
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#healthcommunication #technology #publichealth #openaccess
February 6, 2026 at 11:11 PM
Biomarker analysis of circulating tumor DNA in clinical stage III melanoma patients treated with neoadjuvant immunotherapy combined with targeted therapy
@tamedoncol.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#skincancer #PET #targetedtherapy #oncology #openaccess
February 6, 2026 at 11:09 PM
Incidence of urinary infections and urosepsis after ureteroscopy for stone disease: a systematic review of literature

Therapeutic Advances in Urology
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#UTIs #uretericstone #kidneystone #treatment #medicine #openaccess
February 6, 2026 at 11:07 PM
Vedolizumab in inflammatory bowel disease: pharmacokinetics and the role of immunomodulator co-therapy
@tagastroenterol.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#gastroenterology #crohns #ulcerativecolitis #medicine #treatment #openaccess
February 6, 2026 at 11:04 PM
Prospective Breast Cancer Biomarkers Identified Using miR-526b-Driven Metabolic Alterations
@cancerinformatics.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#cancerresearch #metabolism #diagnostics #openaccess
February 6, 2026 at 10:54 PM
Reposted by Jen L, PhD
New international Delphi consensus clarifies best practices for steroid use in generalized #MyastheniaGravis:

Key takeaways:
👉Aim ≤5 mg/day long‑term
👉Prioritize biologics to reduce OCS burden
👉Individualize tapering strategies
journals.sagepub.com/doi/full/10....
February 5, 2026 at 10:00 AM
Reposted by Jen L, PhD
Top Read Papers on Natural Product Communications - February 2026

💡1. Mechanistic Insights into the Pharmacological Actions of Flavonoids: A Comprehensive Review

journals.sagepub.com/doi/10.1177/...
February 5, 2026 at 10:13 AM
Reposted by Jen L, PhD
Review: Histologic transformation is a key mechanism of resistance in driver‑positive NSCLC, leading to aggressive SCLC, squamous, or neuroendocrine phenotypes.⬇️ summarize mechanisms and treatment options.
🔗 buff.ly/jJq7xOQ
#NSCLC #LungCancer #Oncology #TargetedTherapy
February 4, 2026 at 6:04 PM